- Report
- August 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2024
- 85 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2022
- 308 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- October 2023
- 47 Pages
India
From €333EUR$350USD£280GBP
- Report
- October 2023
- 95 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 108 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2022
Global
From €9031EUR$9,500USD£7,587GBP
- Report
- October 2021
Global
From €9031EUR$9,500USD£7,587GBP
The Specialty Pharmaceutical market is a subset of the Pharmaceutical industry that focuses on the development, production, and distribution of drugs that require special handling, storage, and administration. These drugs are typically used to treat complex, chronic, and rare diseases, and are often more expensive than traditional pharmaceuticals. Specialty Pharmaceuticals are typically biologics, which are drugs derived from living organisms, or small molecule drugs, which are chemically synthesized.
Specialty Pharmaceuticals are typically distributed through specialty pharmacies, which are pharmacies that have specialized training and expertise in the handling and administration of these drugs. Specialty pharmacies also provide additional services such as patient education, drug therapy management, and reimbursement support.
Some companies in the Specialty Pharmaceutical market include AbbVie, Amgen, Biogen, Gilead Sciences, and Novartis. Show Less Read more